Capstone Holding Corp. lowers convertible note conversion price to $1.00
NEW YORK - In a recent disclosure to the Irish Takeover Panel, Tang Capital Management, LLC reported holding a 1.6% interest in Mural Oncology Plc, a company currently involved in takeover discussions. The disclosure, dated April 22, 2025, showed that Tang Capital Management, through its entities Tang Capital Partners (WA:CPAP), LP and Tang Capital Partners International, LP, owns 270,231 shares in the biotechnology firm.
The filing revealed that Tang Capital Management had engaged in the sale of Mural Oncology shares on April 22, 2025, with transactions including 73,849 shares sold at $2.71 each and 400 shares at $2.78 per unit. These sales have contributed to Tang Capital’s current holding in the company.
Mural Oncology has not been identified as having any indemnity or option arrangements, nor agreements, arrangements, or understandings related to the voting rights of any relevant securities under any option or in relation to any derivatives referenced on the form. The disclosure stated that no supplemental Form 8 is attached.
The investment management firm, led by CFO Michael Hearne, has not disclosed any dealings in respect of other parties to the offer. The information provided is based on a press release statement and is intended to inform the public of notable shareholdings and transactions in accordance with the Irish Takeover Panel’s rules.
This disclosure is a regulatory requirement and does not necessarily indicate Tang Capital’s strategic intentions regarding Mural Oncology. Investors and the market at large often monitor such disclosures to gauge investment firm activities and interests in companies subject to takeover speculation.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.